Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P1.01-021 - FISH and IHC Discordance in ALK Rearranged Non Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Akhil Kapoor | Author(s): V. Noronha, A. Joshi, Vijay Patil, R. Kaushal, A. Mahajan, A. Janu, K. Prabhash
- Abstract
Loading... -
+
P1.01-023 - ALK-Positive NSCLC: A TMH Experience
09:30 - 09:30 | Presenter: Vikas Talreja | Author(s): V. Noronha, A. Joshi, Vijay Patil, Alok Goel, Akhil Kapoor, R. Kumar, A. Janu, A. Mahajan, K. Prabhash
- Abstract
Loading... -
+
P1.01-024 - Plasma Circulating cfDNA as a Potential Biomarker in Clinical Management of NSCLC: Experience of Tata Memorial Hospital, India
09:30 - 09:30 | Presenter: Anuradha Choughule | Author(s): K. Prabhash, V. Naronha, Vijay Patil, A. Joshi, V. Hariniv, R. Prasad
- Abstract
Loading...
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-021 - A Prospective Observational Study to Evaluate Incidence of Thromboembolic Events during Platinum Based Chemotherapy in Lung Cancer
09:30 - 09:30 | Presenter: Vikas Talreja | Author(s): A. Joshi, V. Noronha, Vijay Patil, K. Prabhash, S. Kate
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-051 - Randomized Study of Pemetrexed Versus Erlotinib as Maintenance Therapy in Metastatic /Locally Advanced EGFR Mutation Negative NSCLC
09:00 - 09:00 | Presenter: Vikas Talreja | Author(s): A. Joshi, V. Noronha, V. Patil, M. Sharma, C. Vora, S. Goud, S. More, S. Shah, A. Mahajan, A. Janu, R. Kaushal, K. Prabhash
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-027 - Comparative Longitudinal Toxicity Analysis of EGFR Mutated NSCLC Treated with Either Pemetrexed Carboplatin or Gefitinib
09:30 - 09:30 | Presenter: Mansi Sharma | Author(s): Vijay Patil, A. Joshi, V. Noronha, A. Bhattarjee, S. Goud, S.B. More, A. Ramaswamy, A.P. Karpe, N. Pande, A. Chandrasekharan, Alok Goel, Vikas Talreja, K. Prabhash
- Abstract
Loading...
-
+
P2.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P2.04-005 - GEOMETRY Mono-1: Phase II, Multicenter Study of MET Inhibitor Capmatinib (INC280) in EGFR Wt, MET-Dysregulated Advanced NSCLC
09:30 - 09:30 | Presenter: Jürgen Wolf | Author(s): Ji-Youn Han, Makoto Nishio, P. Souquet, Luis Paz-Ares, F. De Marinis, Takashi Seto, M. De Jonge, T.M. Kim, Johan F. Vansteenkiste, Daniel SW Tan, Edward Brian Garon, H.J. Groen, Maximilian Johannes Hochmair, Enriqueta Felip, Noemi Reguart, M. Thomas, T.R. Overbeck, K. Ohashi, M. Giovannini, R. Yura, A. Joshi, M. Akimov, R. Heist
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-076 - QTWiST Analysis to Compare the Benefit of Gefitinib Versus Pemetrexed Platinum for Patients with EGFR Mutated NSCLC
09:30 - 09:30 | Presenter: Vijay Patil | Author(s): V. Noronha, A. Joshi, Alok Goel, Vikas Talreja, A. Kapoor, R. Kumar, A. Mahajan, A. Janu, K. Prabhash
- Abstract
Loading...
-
+
P3.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P3.03-015 - ROS-1 Rearranged Non Small Cell Lung Cancer and Crizotinib: An Indian Experience
09:30 - 09:30 | Presenter: Vikas Talreja | Author(s): Vijay Patil, A. Joshi, V. Noronha, C. Mv, R. Kaushal, A. Mahajan, A. Janu, K. Prabhash
- Abstract
Loading...